Literature DB >> 22901100

Myofibroblastoma: report of a rare entity in the pediatric population.

Rose Chami1, Kjetil Ertresvaag, Georges Azzie, Paul Scott Thorner.   

Abstract

Fibroblastic and myofibroblastic tumors constitute an important group of neoplasms in children and adolescents. These span the full spectrum of clinical behavior, ranging from benign to intermediate and malignant. We report a case of a benign mesenchymal tumor with myofibroblastic differentiation in a 9-year-old girl arising in the left groin that met the histologic features described for myofibroblastoma in adults. Two types are recognized in adults: angiomyofibroblastoma and mammary-type myofibroblastoma of soft tissue. Our case shared features of both these subtypes but was not typical of either one, and we therefore designated our case simply as "myofibroblastoma." Our case showed expression of estrogen receptor protein, which is characteristic of adult lesions, but not a deletion of 13q14, as has been reported in some adult cases. In the English-language literature, only 6 cases have been reported in patients under 21 years of age, and all but 1 were teenagers. Pediatric surgeons, oncologists, and pathologists should be aware that such a benign entity can occur in this patient population and could be confused with other lesions, including malignant ones.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22901100     DOI: 10.2350/12-05-1204-CR.1

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  3 in total

Review 1.  Mammary-type myofibroblastoma of the psoas.

Authors:  Kamran Khan; Arun A Mavanur
Journal:  BMJ Case Rep       Date:  2016-10-14

2.  Myofibroblastoma of the mandible in a 3-year-old child.

Authors:  Saad Hajeri; Abdulsalam Al Jabab; Manal Al Sheddi; Hanadi Fatani
Journal:  Oral Maxillofac Surg       Date:  2015-08-19

3.  Clinicopathologic evaluation of myofibroblastoma: A study in two hospitals.

Authors:  Seul Ki Kim; Ji Sun Lee; Su Been Hong; Jung Ryeol Lee; Byung Chul Jee; Chang Suk Suh; Seok Hyun Kim
Journal:  Obstet Gynecol Sci       Date:  2017-01-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.